Quanticate Launches its New Candidate Management Unit
Expanded Operations to Support Clinical Trials in Europe and the US
Cambridge, MA and London, UK – March 17, 2009
-Quanticate, a global biometrics clinical research organization (CRO), today announced it has launched its new Candidate Management Unit (CMU), a component of “Quanticate People.” Designed specifically to support both its customers and candidates, the CMU strengthens Quanticate’s recruitment offering and further expands its professional services within the clinical trials sector.
The new CMU draws on the company’s history of biometrics and recruitment to support customers by providing them with a highly trained pan-European talent pool, and is currently identifying professionals in the US ahead of an expected expansion of Quanticate’s recruitment services later this year.
Quanticate People is now comprised of two specific groups. The customer relationship function is a consultative group that works closely with customers to identify specific talent needed to support their development programs. The CMU identifies and manages individuals who meet these specific requirements, providing the necessary technical training where needed for candidates serving in such roles as Clinical Research Associates, Biometricians and Project Managers.
“The strength of our recruitment program comes from the long-time association we’ve had with our candidates and the training we can provide to make sure that they are completely current with the technologies and qualifications they need to provide the best job possible,” said Tom Griffith, Manager of Quanticate’s Recruitment Business “We’ve been able to track many of them throughout their careers, which gives us a great advantage in being able to place the person who is most qualified and suitable for the task at hand. The CMU allows us to dedicate expertise to fully leverage these benefits.”
Quanticate announced the opening of its US operations in June 2008, and Andrew MacGarvey was recently appointed to lead and expand Quanticate’s services there. “We will continue to add professional services to better support our customers both in the US and abroad,” MacGarvey added. “The new model being deployed by Quanticate People is yet another indicator of that commitment.”
About Quanticate
Quanticate, with headquarters in Cambridge, MA and London, UK, is the largest global biometrics company with full service clinical trial capabilities. Trusted and respected throughout the industry, Quanticate delivers premium quality clinical trial services, consultancy, highly scalable on-and off-site data management, statistical programming and analysis, and medical writing solutions. Dedicated staff recruitment services are provided through Quanticate People. With resources spanning three continents, Quanticate is renowned for its dedication to clients, world-class service and superior results. In working closely with biotech, pharmaceutical and medical device companies, Quanticate prides itself in being a seamless extension of its customers’ internal teams offering the flexibility to adapt to any technology environment. For more information, visit www.quanticate.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
